News Headlines Article

Nearly 25% of women with early ovarian cancer not given recommended biopsies
USA Today

More than one-quarter of women with apparent early-stage ovarian cancer don’t receive recommended lymph node biopsies to check for cancer spread, which nearly doubles these patients’ risk of death, say U.S. researchers. The team at the University of California Davis Cancer Center and California Cancer Registry analyzed the medical records and cancer registry data of 721 presumed early-stage ovarian cancer patients in California and New York and found that only 72% had lymph nodes from the pelvis and abdomen tested for signs of cancer spread.